Jane E. Kiernan

Jane E. Kiernan has served as a member of board of directors since October 2022. Ms. Kiernan has over 30 years of executive and management leadership in healthcare with both public and private companies. She joined Surgimatix, Inc., a privately-held medical device company pioneering a novel suture-based soft tissue fixation technology for minimally invasive surgical procedures, as Chief Business Officer in May 2020 and became its Chief Executive Officer and a board member in February 2022. In January 2018, Ms. Kiernan cofounded K2 Biotechnology Ventures, an organization engaged in developing and commercializing university and medical center innovations in partnership with venture capital, healthcare corporations and philanthropic healthcare foundation partners. From October 2010 to May 2017, Kiernan served as the CEO of Salter Labs, a manufacturer of specialty respiratory and airway management medical devices.

From 2001 to September 2010, Kiernan held executive and general management positions with both Baxter Healthcare Corporation and Allegiance Healthcare Corporation. She currently serves on the board of directors of Axonics, Inc. (NASDAQ: AXNX), a publicly traded medical technology company developing products for women with bladder and bowel dysfunction. She previously served on the board of directors of Salona Global Medical Device Corp (TSXV: SGMD), a publicly traded medical device company, Endologix, Inc. (OTC: ELGXQ), a publicly-traded provider of minimally invasive treatments of aortic disorders, and American Medical Systems, a publicly traded life sciences company acquired by Endo Pharmaceuticals. Kiernan holds a B.S. degree in business from Southern Methodist University.